Argenx, NL0010832176

Argenx stock ends the day 0.21 percent lower at USD 988.20

Published on 09/23/2026 at 22:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, Argenx stock finished at USD 988.20 on Nasdaq, down 0.21 percent. The session ranged from USD 986.56 to USD 1,001.95, while after-hours trading later showed USD 998.51 at 5:57 p.m. ET.

Fotorealistisches Laborpanorama: Wissenschaftler in weißen Kitteln begutachten leuchtende Antikörper-3D-Modelle auf Bildschirmen, Stahltische mit Laborgeräten im Hintergrund
Argenx NL0010832176 Forscher analysieren im modernen Biopharma-Labor leuchtende Antikörper-Strukturen auf großen Monitoren, Illustration mit AI erstellt.

Argenx stock closed at USD 988.20 on Nasdaq on September 23, 2026, down 0.21 percent from the previous close. The U.S.-listed ADRs finished 7.9 percent below the 52-week high of USD 1,072.75 and remained above the 52-week low of USD 661.85.

September 23, 2026 in numbers

Argenx SE (ISIN NL0010832176, Nasdaq: ARGX) traded between USD 986.56 and USD 1,001.95 during the regular session and recorded volume of 231,642 shares. The Nasdaq Composite rose 2.26 percent to 27,122.09 on September 23, 2026, leaving Argenx 2.47 percentage points behind the broader technology-heavy index.

As AD HOC NEWS reported, Vyvgart annual sales exceeded USD 1 billion in its second year on the market, while the report also identified a fourth-quarter empasiprubart trial readout as a development investors are monitoring.

After-hours trading on September 23, 2026

After-hours trading later showed USD 998.51 at 5:57 p.m. ET, up 1.04 percent from the Nasdaq regular-session close. The next U.S. trading session is September 24, 2026, with the share price still positioned below its stated 52-week high.

Disclaimer...

en | NL0010832176 | ARGENX | boerse | 70170399 | bgmi